Science Historical Balance Sheet

SAIC Stock

USD 113.42 0.16 0.14%

Trend analysis of Science Applications International balance sheet accounts such as Total Current Liabilities of 962 M, Total Stockholder Equity of 1.4 B, Property Plant And Equipment Net of 208.6 M or Current Deferred Revenue of 44.7 M provides information on Science Applications' total assets, liabilities, and equity, which is the actual value of Science Applications to its prevalent stockholders. By breaking down trends over time using Science Applications balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Science Applications latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Science Applications is a good buy for the upcoming year.

Science Applications Inventory

2.56 Million

Build AI portfolio with Science Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

About Science Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Science Applications at a specified time, usually calculated after every quarter, six months, or one year. Science Applications Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Science Applications and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Science currently owns. An asset can also be divided into two categories, current and non-current.

Science Applications Balance Sheet Chart

At present, Science Applications' Current Deferred Revenue is projected to decrease significantly based on the last few years of reporting. The current year's Retained Earnings is expected to grow to about 1.6 B, whereas Total Assets are forecasted to decline to about 4.7 B.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Science Applications assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Science Applications books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Science Applications' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Science Applications current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	2.5B	2.2B	2.4B	1.8B
Total Assets	5.5B	5.3B	5.2B	4.7B

Short Long Term Debt Total Total Assets

Science Applications balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Common Stock Shares Outstanding		0.55	-0.11	0.52	0.8	0.65	0.26	0.67	-0.46	0.75	0.46	0.71	-0.22	0.08	0.71	0.69	-0.2	0.06	0.16	0.7	-0.46	0.46	0.4	0.73	0.28	-0.36
Total Assets	0.55		0.66	0.53	0.79	0.95	0.78	0.47	0.46	0.79	0.61	0.33	0.67	0.61	0.33	0.68	0.68	0.83	-0.02	0.44	0.25	0.98	0.87	0.53	0.41	0.56
Short Long Term Debt Total	-0.11	0.66		0.31	0.31	0.43	0.87	0.32	0.87	0.19	0.58	0.16	0.94	0.51	0.16	0.51	0.94	0.9	0.0	0.28	0.71	0.77	0.62	0.34	0.31	0.82
Other Current Liab	0.52	0.53	0.31		0.85	0.43	0.56	0.37	-0.06	0.4	0.12	0.72	0.22	0.12	0.72	0.73	0.24	0.19	0.32	0.66	0.04	0.57	0.4	0.75	0.74	0.02
Total Current Liabilities	0.8	0.79	0.31	0.85		0.77	0.61	0.56	-0.05	0.75	0.41	0.69	0.24	0.31	0.69	0.82	0.28	0.36	0.19	0.69	-0.11	0.77	0.67	0.78	0.65	0.05
Total Stockholder Equity	0.65	0.95	0.43	0.43	0.77		0.58	0.39	0.27	0.86	0.54	0.26	0.49	0.58	0.26	0.58	0.49	0.69	-0.12	0.36	0.09	0.87	0.82	0.44	0.3	0.42
Property Plant And Equipment Net	0.26	0.78	0.87	0.56	0.61	0.58		0.63	0.6	0.42	0.69	0.45	0.77	0.53	0.45	0.74	0.77	0.79	0.11	0.52	0.48	0.86	0.77	0.62	0.47	0.58
Current Deferred Revenue	0.67	0.47	0.32	0.37	0.56	0.39	0.63		-0.06	0.51	0.81	0.72	0.11	0.19	0.72	0.75	0.13	0.3	0.22	0.79	-0.22	0.5	0.49	0.77	0.19	-0.13
Net Debt	-0.46	0.46	0.87	-0.06	-0.05	0.27	0.6	-0.06		0.0	0.32	-0.34	0.94	0.51	-0.34	0.04	0.93	0.85	-0.13	-0.19	0.74	0.55	0.49	-0.16	0.05	0.96
Retained Earnings	0.75	0.79	0.19	0.4	0.75	0.86	0.42	0.51	0.0		0.47	0.31	0.22	0.68	0.31	0.52	0.27	0.42	-0.31	0.38	-0.33	0.7	0.78	0.45	0.45	0.09
Accounts Payable	0.46	0.61	0.58	0.12	0.41	0.54	0.69	0.81	0.32	0.47		0.5	0.43	0.31	0.5	0.7	0.45	0.63	0.01	0.62	0.13	0.63	0.59	0.61	-0.02	0.25
Cash	0.71	0.33	0.16	0.72	0.69	0.26	0.45	0.72	-0.34	0.31	0.5		-0.09	-0.14	1.0	0.89	-0.07	0.0	0.33	0.94	-0.14	0.36	0.19	0.97	0.41	-0.36
Non Current Assets Total	-0.22	0.67	0.94	0.22	0.24	0.49	0.77	0.11	0.94	0.22	0.43	-0.09		0.61	-0.09	0.3	0.99	0.92	-0.1	0.05	0.69	0.75	0.66	0.11	0.25	0.94
Non Currrent Assets Other	0.08	0.61	0.51	0.12	0.31	0.58	0.53	0.19	0.51	0.68	0.31	-0.14	0.61		-0.14	0.19	0.67	0.59	-0.65	-0.08	0.12	0.61	0.79	0.05	0.51	0.51
Cash And Short Term Investments	0.71	0.33	0.16	0.72	0.69	0.26	0.45	0.72	-0.34	0.31	0.5	1.0	-0.09	-0.14		0.89	-0.07	0.0	0.33	0.94	-0.14	0.36	0.19	0.97	0.41	-0.36
Net Receivables	0.69	0.68	0.51	0.73	0.82	0.58	0.74	0.75	0.04	0.52	0.7	0.89	0.3	0.19	0.89		0.33	0.42	0.22	0.89	0.12	0.71	0.53	0.97	0.49	0.04
Good Will	-0.2	0.68	0.94	0.24	0.28	0.49	0.77	0.13	0.93	0.27	0.45	-0.07	0.99	0.67	-0.07	0.33		0.89	-0.18	0.06	0.64	0.76	0.71	0.13	0.33	0.9
Non Current Liabilities Total	0.06	0.83	0.9	0.19	0.36	0.69	0.79	0.3	0.85	0.42	0.63	0.0	0.92	0.59	0.0	0.42	0.89		-0.04	0.17	0.59	0.87	0.74	0.22	0.13	0.88
Inventory	0.16	-0.02	0.0	0.32	0.19	-0.12	0.11	0.22	-0.13	-0.31	0.01	0.33	-0.1	-0.65	0.33	0.22	-0.18	-0.04		0.36	0.09	0.04	-0.28	0.27	-0.15	-0.09
Other Current Assets	0.7	0.44	0.28	0.66	0.69	0.36	0.52	0.79	-0.19	0.38	0.62	0.94	0.05	-0.08	0.94	0.89	0.06	0.17	0.36		-0.14	0.47	0.29	0.94	0.29	-0.2
Other Stockholder Equity	-0.46	0.25	0.71	0.04	-0.11	0.09	0.48	-0.22	0.74	-0.33	0.13	-0.14	0.69	0.12	-0.14	0.12	0.64	0.59	0.09	-0.14		0.34	0.12	-0.01	0.01	0.74
Total Liab	0.46	0.98	0.77	0.57	0.77	0.87	0.86	0.5	0.55	0.7	0.63	0.36	0.75	0.61	0.36	0.71	0.76	0.87	0.04	0.47	0.34		0.86	0.56	0.46	0.62
Property Plant And Equipment Gross	0.4	0.87	0.62	0.4	0.67	0.82	0.77	0.49	0.49	0.78	0.59	0.19	0.66	0.79	0.19	0.53	0.71	0.74	-0.28	0.29	0.12	0.86		0.37	0.44	0.53
Total Current Assets	0.73	0.53	0.34	0.75	0.78	0.44	0.62	0.77	-0.16	0.45	0.61	0.97	0.11	0.05	0.97	0.97	0.13	0.22	0.27	0.94	-0.01	0.56	0.37		0.48	-0.17
Short Term Debt	0.28	0.41	0.31	0.74	0.65	0.3	0.47	0.19	0.05	0.45	-0.02	0.41	0.25	0.51	0.41	0.49	0.33	0.13	-0.15	0.29	0.01	0.46	0.44	0.48		0.05
Intangible Assets	-0.36	0.56	0.82	0.02	0.05	0.42	0.58	-0.13	0.96	0.09	0.25	-0.36	0.94	0.51	-0.36	0.04	0.9	0.88	-0.09	-0.2	0.74	0.62	0.53	-0.17	0.05

Click cells to compare fundamentals

Science Applications Account Relationship Matchups

Science Applications balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	58.7M	58.1M	55.8M	53.7M	50.5M	97.6M
Total Assets	5.7B	5.7B	5.5B	5.3B	5.2B	4.7B
Short Long Term Debt Total	2.7B	2.7B	2.5B	2.2B	2.4B	1.8B
Other Current Liab	690M	592M	471M	514M	452M	430.7M
Total Current Liabilities	1.3B	1.4B	1.1B	1.2B	1.4B	962.0M
Total Stockholder Equity	1.5B	1.6B	1.7B	1.8B	1.6B	1.4B
Property Plant And Equipment Net	344M	309M	250M	243M	268M	208.6M
Current Deferred Revenue	41M	82M	55M	48M	43.2M	44.7M
Net Debt	2.5B	2.6B	2.4B	2.2B	2.3B	1.5B
Retained Earnings	627M	818M	1.0B	1.4B	1.6B	1.6B
Accounts Payable	517M	612M	624M	567M	631M	414.1M
Cash	171M	106M	109M	94M	56M	53.2M
Non Current Assets Total	4.4B	4.5B	4.7B	4.2B	4.1B	2.8B
Non Currrent Assets Other	73M	84M	97M	167M	194M	203.7M
Cash And Short Term Investments	171M	106M	109M	94M	56M	53.2M
Net Receivables	962M	1.0B	936M	914M	1B	795.4M
Good Will	2.8B	2.9B	2.9B	2.9B	3.3B	1.9B
Liabilities And Stockholders Equity	5.7B	5.7B	5.5B	5.3B	5.2B	4.7B
Non Current Liabilities Total	2.9B	2.8B	2.7B	2.4B	2.3B	2.0B
Inventory	143M	156M	142M	3M	2.7M	2.6M
Other Current Assets	72M	59M	78M	120M	20M	19M
Other Stockholder Equity	1.0B	838M	637M	337M	387.6M	465.7M
Total Liab	4.2B	4.1B	3.8B	3.5B	3.7B	3.3B
Property Plant And Equipment Gross	344M	309M	250M	427M	468M	258.0M
Total Current Assets	1.3B	1.3B	1.2B	1.1B	1.2B	1.2B
Accumulated Other Comprehensive Income	(89M)	(37M)	22M	16M	12M	12.6M
Short Term Debt	68M	148M	31M	77M	313M	328.7M
Intangible Assets	1.1B	1.1B	1.0B	894M	779M	561.1M
Other Liab	102M	133M	244M	203M	233.5M	245.1M
Other Assets	100M	123M	138M	129M	148.4M	155.8M
Long Term Debt	2.4B	2.4B	2.3B	2.0B	1.9B	1.5B
Property Plant Equipment	91M	344M	309M	92M	105.8M	119.9M
Common Stock	1.5B	1.4B	1.6B	1.7B	1.9B	2.0B
Net Tangible Assets	(1.3B)	(2.4B)	(2.4B)	(2.1B)	(1.9B)	(2.0B)
Retained Earnings Total Equity	506M	627M	818M	1.0B	1.2B	1.2B
Long Term Debt Total	1.9B	2.4B	2.4B	2.3B	2.7B	1.7B
Capital Surpluse	983M	1.0B	838M	637M	732.6M	670.1M
Non Current Liabilities Other	244M	160M	218M	174M	169M	123.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GOOG	Alphabet Inc Class C
V	Visa Class A

When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:

How To Invest In Science

Details

Is Science Stock a good investment?

Details

What is Science Applications' Net Worth?

Details

Largest IT Consulting & Other Services Companies

View

Largest Information Technology Services Companies

View

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is IT Consulting & Other Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.04)

Dividend Share

1.48

Earnings Share

7.11

Revenue Per Share

152.933

Quarterly Revenue Growth

0.016

The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Science Historical Balance Sheet

Science Applications Inventory

2.56 Million

About Science Balance Sheet Analysis

Science Applications Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Science Applications balance sheet Correlations

Science Applications Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Science Applications balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Total Current Assets	+ 0.97	Cash
Total Current Assets	+ 0.97	Cash And Short Term Investments
Total Current Assets	+ 0.97	Net Receivables

Inventory	- 0.65	Non Currrent Assets Other
Other Stockholder Equity	- 0.46	Common Stock Shares Outstanding
Net Debt	- 0.46	Common Stock Shares Outstanding
Intangible Assets	- 0.36	Cash And Short Term Investments
Intangible Assets	- 0.36	Cash
Intangible Assets	- 0.36	Common Stock Shares Outstanding